U.S. markets closed
  • S&P 500

    4,455.48
    +6.50 (+0.15%)
     
  • Dow 30

    34,798.00
    +33.18 (+0.10%)
     
  • Nasdaq

    15,047.70
    -4.54 (-0.03%)
     
  • Russell 2000

    2,248.07
    -10.97 (-0.49%)
     
  • Crude Oil

    73.98
    +0.68 (+0.93%)
     
  • Gold

    1,749.10
    -0.70 (-0.04%)
     
  • Silver

    22.12
    -0.52 (-2.31%)
     
  • EUR/USD

    1.1725
    -0.0022 (-0.19%)
     
  • 10-Yr Bond

    1.4600
    +0.0500 (+3.55%)
     
  • GBP/USD

    1.3673
    -0.0048 (-0.35%)
     
  • USD/JPY

    110.7330
    +0.4320 (+0.39%)
     
  • BTC-USD

    42,877.95
    -1,754.66 (-3.93%)
     
  • CMC Crypto 200

    1,067.20
    -35.86 (-3.25%)
     
  • FTSE 100

    7,051.48
    -26.87 (-0.38%)
     
  • Nikkei 225

    30,248.81
    +609.41 (+2.06%)
     

Johnson & Johnson Legal Representatives Exploring Putting Talc Lawsuits Into Subsidiary For Bankruptcy Filing: Reuters

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Johnson & Johnson (NYSE: JNJ) is exploring a plan to offload liabilities from its Baby Powder litigation into a newly created business that would then seek bankruptcy protection, Reuters reports.

  • During settlement discussions, one of the Company's attorneys has told plaintiffs' lawyers that J&J could pursue the bankruptcy plan, resulting in lower payouts for cases that do not settle beforehand, some of the people said.

  • According to the report, J&J has not yet decided whether to pursue the bankruptcy plan. It is not clear whether the Company has retained restructuring lawyers to help explore the bankruptcy plan.

  • The Company faces legal actions from several plaintiffs alleging its Baby Powder and other talc products contained asbestos and caused cancer.

  • The plaintiffs include women who have ovarian cancer and others battling mesothelioma.

  • Attorneys representing the plaintiffs are denouncing the Company over reports it is considering bankruptcy to avoid financial responsibility.

  • Last month, the U.S. Supreme Court denied hearing JNJ's appeal of a $2.1 billion verdict from a 2018 trial.

  • Last week, Johnson & Johnson had to recall five of its sunscreen products after some samples were found to contain low levels of benzene, a chemical that can cause cancer with repeated exposure.

  • Price Action: JNJ shares are down 0.81% at $166.74 premarket on the last check Monday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.